Herbalife's 15-minute chart shows Bollinger Bands narrowing, KDJ death cross.
ByAinvest
Thursday, Jul 31, 2025 12:21 pm ET1min read
BINI--
Herbalife's Q1 2025 earnings report showed earnings of $0.59 per share, beating analyst estimates by $0.19. However, revenue declined by 3.4% year-over-year, driven by a 3.4% drop in sales. The company's net margin was 5.66%, and its return on equity was negative at 23.75% [1].
Several hedge funds have increased their positions in Herbalife. AQR Capital Management LLC grew its holdings by 236.8% during the 1st quarter, while UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position by 3.3%. Empowered Funds LLC boosted its holdings by 12.9% and MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position by 4.4% [1].
Analysts have mixed views on Herbalife's future. Mizuho upgraded its price target from $8.00 to $9.00 with a "neutral" rating, while Citigroup cut its target price from $13.00 to $11.00 with a "buy" rating. Wall Street Zen also raised its rating from "hold" to "buy" [1].
According to the 15-minute chart for Herbalife, the Bollinger Bands are currently narrowing, and a KDJ Death Cross has been triggered at 12:15 on July 31, 2025. This indicates a decline in the magnitude of stock price fluctuations, as well as a shift in momentum towards a downward trend, which may continue to intensify [2].
References:
[1] https://www.marketbeat.com/instant-alerts/herbalife-hlf-expected-to-announce-quarterly-earnings-on-wednesday-2025-07-30/
[2] https://seekingalpha.com/article/4804225-fitlife-brands-premium-valuation-faces-uncertain-rebound-a-hold-for-now
C--
HLF--
MFG--
According to the 15-minute chart for Herbalife, the Bollinger Bands are currently narrowing, and a KDJ Death Cross has been triggered at 12:15 on July 31, 2025. This indicates a decline in the magnitude of stock price fluctuations, as well as a shift in momentum towards a downward trend, which may continue to intensify.
Herbalife (HLF) is set to release its Q2 2025 quarterly earnings on August 6th, with analysts expecting earnings of $0.53 per share and revenue of $1.27 billion. The company's stock has shown mixed performance, with recent insider buying and analyst ratings adding to the intrigue. Analysts have given Herbalife a "Moderate Buy" rating with a consensus price target of $11.50 [1].Herbalife's Q1 2025 earnings report showed earnings of $0.59 per share, beating analyst estimates by $0.19. However, revenue declined by 3.4% year-over-year, driven by a 3.4% drop in sales. The company's net margin was 5.66%, and its return on equity was negative at 23.75% [1].
Several hedge funds have increased their positions in Herbalife. AQR Capital Management LLC grew its holdings by 236.8% during the 1st quarter, while UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position by 3.3%. Empowered Funds LLC boosted its holdings by 12.9% and MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position by 4.4% [1].
Analysts have mixed views on Herbalife's future. Mizuho upgraded its price target from $8.00 to $9.00 with a "neutral" rating, while Citigroup cut its target price from $13.00 to $11.00 with a "buy" rating. Wall Street Zen also raised its rating from "hold" to "buy" [1].
According to the 15-minute chart for Herbalife, the Bollinger Bands are currently narrowing, and a KDJ Death Cross has been triggered at 12:15 on July 31, 2025. This indicates a decline in the magnitude of stock price fluctuations, as well as a shift in momentum towards a downward trend, which may continue to intensify [2].
References:
[1] https://www.marketbeat.com/instant-alerts/herbalife-hlf-expected-to-announce-quarterly-earnings-on-wednesday-2025-07-30/
[2] https://seekingalpha.com/article/4804225-fitlife-brands-premium-valuation-faces-uncertain-rebound-a-hold-for-now
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet